Why Moderna Inc (MRNA) Stock Is Rising
As of 2026-08-25, Moderna Inc (MRNA) has a next-year EPS growth estimate of 41.78%. Featured in 4 EPS revision reports, most recently on 2026-07-07.
Why MRNA Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Moderna Inc's next-year EPS growth estimate from 42.55% to 42.56% on 2026-08-19.
- ·Current-Year Growth: Projected at -16.52%, supporting the forward estimate revision.
News Context
The primary structural driver is the slight upward revision
Generated 2026-08-25 · news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 41.78%
- EPS growth this year
- -16.52%
- EPS next quarter (est)
- -$1.16
- Last price
- $158.83
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 41.78% | -16.52% | -$1.16 | $158.83 |
| 2026-08-24 | 42.23% | -16.92% | -$1.16 | $138.89 |
| 2026-08-23 | 42.58% | -17.04% | -$1.16 | $145.13 |
| 2026-08-21 | 42.58% | -17.04% | -$1.16 | $145.13 |
| 2026-08-20 | 42.56% | -17.04% | -$1.16 | $133.32 |
| 2026-08-19 | 42.56% | -17.04% | -$1.16 | $174.38 |
| 2026-08-18 | 42.55% | -17.04% | -$1.16 | $62.96 |
| 2026-08-17 | 42.55% | -17.04% | -$1.16 | $64.46 |
| 2026-08-16 | 42.55% | -17.04% | -$1.16 | $63.32 |
| 2026-08-14 | 42.55% | -17.04% | -$1.16 | $63.32 |
| 2026-08-13 | 42.55% | -17.04% | -$1.16 | $63.65 |
| 2026-08-12 | 42.55% | -17.04% | -$1.16 | $63.67 |
| 2026-08-11 | 42.76% | -16.71% | -$1.16 | $60.57 |
| 2026-08-10 | 42.76% | -16.71% | -$1.16 | $59.81 |
| 2026-08-09 | 42.76% | -16.71% | -$1.16 | $59.17 |
| 2026-08-07 | 42.76% | -16.71% | -$1.16 | $59.17 |
| 2026-08-06 | 42.68% | -16.70% | -$1.16 | $53.86 |
| 2026-08-05 | 42.68% | -16.70% | -$1.16 | $56.26 |
| 2026-08-04 | 42.68% | -16.70% | -$1.16 | $56.99 |
| 2026-08-03 | 42.49% | -17.52% | -$1.19 | $55.14 |
| 2026-08-02 | 45.10% | -20.49% | -$1.38 | $54.82 |
| 2026-07-31 | 45.73% | -19.96% | -$1.98 | $54.82 |
| 2026-07-30 | 44.93% | -19.36% | -$2.03 | $57.92 |
| 2026-07-29 | 44.96% | -19.42% | -$2.03 | $54.49 |
| 2026-07-28 | 44.96% | -19.42% | -$2.03 | $55.81 |
| 2026-07-27 | 44.93% | -19.47% | -$2.03 | $55.63 |
| 2026-07-26 | 44.95% | -19.33% | -$2.03 | $54.07 |
| 2026-07-24 | 44.95% | -19.33% | -$2.03 | $54.07 |
| 2026-07-23 | 44.95% | -19.33% | -$2.03 | $57.02 |
| 2026-07-22 | 44.94% | -19.33% | -$2.03 | $58.07 |
Reports Featuring MRNA
- 2026-07-07
WBX +40.8% Leads EPS Revision Winners; NMAX Surges on 217.8pp EPS Upgrade
- 2026-07-06
Stock Surge Alert: WBX +47%, IOT +29%, MRNA +22% on EPS Revisions
- 2026-07-02
Top Stock Gainers Driven by EPS Estimate Revisions: QNRX Up 40.9%, IOT Up 24% - July 2, 2026
- 2026-07-01
Top EPS Revision-Driven Movers: QNRX Surges +44.9% as NMAX Sees 376.9% Growth Estimate
Recent News
- Moderna Shares Rebound After Pullback Following Cancer Vaccine RallyInvestorsHub
- Analysts See Drastic Change For This Particular Part Of HealthcareInvestor's Business Daily
- Thank Moderna for the Healthcare Sector's Standout WeekBarrons.com
- Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech's Biggest PlayersBarrons.com
- Investing.coms stocks of the weekInvesting.com
- Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into BiotechInvestor's Business Daily
- Stock Market Rally Buckles; Moderna, Gold, Bitcoin Surge While Walmart Tumbles: Weekly ReviewInvestor's Business Daily
- Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.Barrons.com
- Moderna, Robinhood, Ross Stores, and More Stocks That Explain Today's MarketBarrons.com
- Crypto stocks rise on Bitcoin's rally, and other early market moversMarketWatch
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Moderna Inc (MRNA) stock go up recently?▾
Moderna Inc (MRNA) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 42.55% to 42.56% on 2026-08-19. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Moderna Inc's next-year EPS growth estimate?▾
As of 2026-08-25, Moderna Inc (MRNA) has a next-year EPS growth estimate of 41.78%, based on analyst consensus.
When was the latest EPS estimate revision for MRNA?▾
The most recent revision occurred on 2026-08-25, when analysts adjusted the next-year EPS growth estimate from 42.23% to 41.78%.
What sector and industry does Moderna Inc belong to?▾
Moderna Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MRNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Moderna Inc (MRNA) appears here because it was detected by our daily top-EPS-revision-performer screen.